SERB PHARMACEUTICALS
LIVE

Serial Number

79398397

Owner

SERB

Attorney

Sherry L. Rollo

Filing Date

Jan 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SERB PHARMACEUTICALS Trademark

Serial Number: 79398397 • Registration: 7862495

SERB PHARMACEUTICALS is a trademark filed by SERB on January 15, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SERB (10 trademarks)

53, rue Villiers de l'Isle Adam
Paris 75020 , FR

Entity Type: 99

Trademark Details

Filing Date

January 15, 2024

Registration Date

July 15, 2025

Published for Opposition

May 27, 2025

Goods & Services

Pharmaceutical preparations, medicines and substances, namely, pharmaceutical preparations for treating poisonings, overdoses of any type, allergies, snake bites, exposure to nuclear radiations, infections, tumors, heart diseases, blood diseases, skin diseases, gastric diseases, liver diseases, neurological diseases, ophthalmological diseases, lung diseases, rheumatological diseases, rare ocular diseases; Pharmaceutical preparations for the treatment of snake bite venom; Pharmaceutical preparations for the treatment of digoxin toxicity and overdose; Pharmaceutical preparations for the treatment of methotrexate toxicity and overdose; Pharmaceutical preparations, namely, potassium iodide, for the treatment of exposure to nuclear radiation; Pharmaceutical preparations for the treatment of cyanide poisoning; Antidotes; veterinary preparations, medicines and substances, namely, veterinary preparations of snake bite venom to treat snake bites, veterinary preparations for the treatment of digoxin toxicity and overdose, veterinary preparations for the treatment of methotrexate toxicity and overdose, veterinary preparations for the treatment of cyanide poisoning; Biological preparations for medical, pharmaceutical and veterinary use, namely, biological preparations for the treatment of cancer; radioactive substances for medical use; dietetic beverages and foods adapted for medical use; nutritional supplements for medical use; diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; radiological contrast substances for medical use; herbal tinctures for medical use; surgical implants made of living tissue; medical and veterinary microbial media, namely, cell culture media for medical and veterinary use; cultures of microorganisms for medical or veterinary use; antibiotic preparations; dressings for medical use.

Chemical preparations for scientific use, other than for medical or veterinary use; Chemical substances for scientific use for analyses in laboratories, other than for medical or veterinary use; chemical preparations and substances with or without coloring agents for laboratory analyses, other than for medical or veterinary use; chemical preparations for scientific purposes other than for medical or veterinary use; diagnostic preparations and substances in the nature of chemicals with or without coloring agents other than for medical or veterinary use, namely, chemical diagnostic reagents for industrial purposes; chemical additives with or without coloring agents used in the composition of diagnostic preparations and substances, namely, chemical additives for use in the manufacture of pharmaceuticals; chemical reagents with or without coloring agents, other than for medical or veterinary use, namely, chemical reagents for non-medical purposes; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of snake bite venom, the treatment of digoxin toxicity and overdose, the treatment of methotrexate toxicity and overdose, the treatment of exposure to nuclear radiation and the treatment of cyanide poisoning.

Surgical apparatus and instruments for medical, dental and veterinary use; infusion apparatus for therapeutic use; thermometers for medical use; Artificial implants, namely, implants consisting of artificial materials; stents; Dental prostheses; cardiac pacemakers; lenses in the nature of intraocular prostheses for surgical implantation; Orthopedic articles, namely, orthopedic braces for the prevention and the correction of disorders of the musculoskeletal system affecting bones, joints, muscles, tendons and nerves; x-ray apparatus for medical use; Electromagnetic medical diagnostic imaging apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic equipment, namely, diagnostic penlights for medical purposes

Medical services; medical assistance; veterinary services; consultation with respect to pharmacy, namely, pharmaceutical consultation.

Medical research services; Scientific research for medical use; pharmaceutical diagnostic testing services, namely, testing of pharmaceuticals; pharmaceutical diagnostic testing services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Research and development of new products; assessment in scientific and technical fields provided by engineers, namely, consulting in the field of engineering; Appraisals in the fields of science and technology provided by engineers, namely, conducting scientific feasibility studies; scientific research; Technical and scientific studies, namely, conducting scientific feasibility studies

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 26, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 6, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 26, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 15, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 24, 2025 ERFR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 23, 2025 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 3, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 3, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 3, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 13, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 12, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2024 REPR